Send to

Choose Destination
Blood Res. 2017 Dec;52(4):254-263. doi: 10.5045/br.2017.52.4.254. Epub 2017 Dec 26.

Management of immune thrombocytopenia: Korean experts recommendation in 2017.

Author information

Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea.
Department of Internal Medicine, Ewha Womans' University School of Medicine, Seoul, Korea.
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Pediatrics, Chungnam National University School of Medicine, Daejeon, Korea.
Department of Internal Medicine, Seoul National University Hospital, Korea.
Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea.
Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea.
Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Pediatrics, Chonnam National University Hwasun Hospital, Hwasun, Korea.


Management options for patients with immune thrombocytopenia (ITP) have evolved substantially over the past decades. The American Society of Hematology published a treatment guideline for clinicians referring to the management of ITP in 2011. This evidence-based practice guideline for ITP enables the appropriate treatment of a larger proportion of patients and the maintenance of normal platelet counts. Korean authority operates a unified mandatory national health insurance system. Even though we have a uniform standard guideline enforced by insurance reimbursement, there are several unsolved issues in real practice in ITP treatment. To optimize the management of Korean ITP patients, the Korean Society of Hematology Aplastic Anemia Working Party (KSHAAWP) reviewed the consensus and the Korean data on the clinical practices of ITP therapy. Here, we report a Korean expert recommendation guide for the management of ITP.


Aplastic Anemia Working Party; ITP; Management; Recommendation

Conflict of interest statement

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Publication type

Publication type

Supplemental Content

Full text links

Icon for Korean Society of Hematology Icon for PubMed Central
Loading ...
Support Center